期刊文献+

美国非酒精性脂肪性肝病诊疗指南解读 被引量:17

Brief introduction of USA Practice Guideline for the diagnosis and management of non-alcoholic fatty liver disease
下载PDF
导出
摘要 2017年7月17日Hepatology杂志在线发表新版美国《菲酒精性脂肪性肝病诊疗指南》,该指南是对2012年版美国肝脏病学会、美国胃肠病学会、美国胃肠病学院联合发布的实践指南的更新旧。该指南主要依据:(1)对最新发表的非酒精性脂肪性肝病(NAFLD)国际文献(截至2016年8月)的总结和分析;(2)美国医师评估健康实践和设计实践指南手册;(3)美国肝脏病学会的指南政策;以及(4)本文作者和独立审稿人对NAFLD诊疗的相关经验。该指南可供临床医生和卫生技术人员参考。指南的实施在临床上应该因人而异。
出处 《实用肝脏病杂志》 CAS 2017年第5期I0004-I0006,共3页 Journal of Practical Hepatology
关键词 非酒精性脂肪性肝病 诊断 治疗 指南 Non-alcoholic fatty liver disease Diagnosis Therapy Guideline
  • 相关文献

参考文献7

二级参考文献14

  • 1Fattly Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].实用肝脏病杂志,2007,10(1):1-3. 被引量:145
  • 2Masahide Hamaguchi,Takao Kojima,Noriyuki Takeda,Chisato Nagata,Jun Takeda,Hiroshi Sarui,Yutaka Kawahito,Naohisa Yoshida,Atsushi Suetsugu,Takahiro Kato,Junichi Okuda,Kazunori Ida,Toshikazu Yoshikawa.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease[J].World Journal of Gastroenterology,2007,13(10):1579-1584. 被引量:55
  • 3Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non -alcoholic fatty liver disease:Practice guideline by the Mnerican association for the study of liver diseases,American college of gastroenterology,and the American gastroenterological association. Hepatology,2012, doi:10.1002/ hep.25762. [Epub ahead of print].
  • 4Fan, JG,Li, F,Cai, XB,Peng, YD,Ao, QH,Gao, Y.Effects of nonalcoholic fatty liver disease on the development of metabolic disorders[J].中国生物学文摘,2007,21(11):21-22. 被引量:51
  • 5Iser D,Ryan M. Fatty liver disease. A practical guide for GPs[J].Australian Family Physician,2013.444-447.
  • 6European Assiation for the Study of the Liver,European Association for the Study of Diabetes,European Association for the Study of Obesity. Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol, 2016,Epub[ahead of print].
  • 7Bedossa P,FLIP Pathology Consortium. Utility and appropriate- ness of the fatty liver inhibition of progression (FLIP) algo- rithm and steatosis,activity,and fibrosis (SAF) score in the e- valuation of biopsies of nonalcoholic fatty liver disease. Hepa- tology, 2014,60( 2 ):565-575.
  • 8Ratziu V,Bellentani S,Cortez-Pinto H,et al. A position state- ment on NAFLD/NASH based on the EASL 2009 special con- ference. J Hepatol,2010,53(2):372-384.
  • 9贾继东,程留芳,许建明,陈成伟,宋育林,于乐成.常用肝脏生物化学试验的临床意义及评价共识[J].中华保健医学杂志,2010,12(3):161-168. 被引量:12
  • 10张林杉,卞华,颜红梅,夏明锋,常薪霞,高键,高鑫.2型糖尿病患者肝脏脂肪含量与肝病结局的相关性研究[J].中华内分泌代谢杂志,2014,30(1):3-7. 被引量:14

共引文献71

同被引文献144

引证文献17

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部